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Examining the Viability of Computational Psychiatry:
Approaches into the Future
By Mitchell Ostrow1
1
Program in Neuroscience, Yale University; Department of Statistics and Data
Science, Yale University

ABSTRACT
As modern medicine becomes increasingly personalized, psychiatry lags behind, using poorly-understood drugs and therapies to treat mental disorders. With the advent of methods that capture large quantities of data, such as genome-wide analyses or fMRI, machine learning (ML) approaches have become prominent in neuroscience. This is promising for studying the brain’s function, but perhaps more
importantly, these techniques can potentially predict the onset of disorder and treatment response.
Experimental approaches that use naive machine learning algorithms have dominated research in computational psychiatry over the past decade. In a critical review and analysis, I argue that biologically realistic approaches will be more effective in clinical practice, and research trends should reflect this. Hybrid
models are considered, and a brief case study on major depressive disorder is presented. Finally, I propose
a novel four-step approach for the future implementation of computational methods in psychiatric clinics.

INTRODUCTION

sample size; open-source initiatives seek to mitigate this issue by
sharing data (Poldrack & Gorgolewski, 2019). Data preprocessing
techniques in fMRI vary between sites, which have significant influence on results (Smith & Nichols, 2018). Additionally, statistical
techniques used in much of neuroscience are simply out of date.
Linear models are interpretable, but neural systems are highly nonlinear and analyses should reflect this (Friston, 2004).

Psychiatrists traditionally utilize behavior and psychology in the
clinic but have long sought to ground the practice in biology. Unfortunately, contemporary research has yet to translate, due to the
inevitable truth that the brain cannot be carved at its joints. This
means that enormous neural complexity has prevented modern
methods from sufficiently elucidating pathophysiological processes. Similarly, the conceptual bridges between cellular biology, sys- In this paper, I analyze the effectiveness of computational tools for
tems neuroscience, and behavior are shaky given the limits of neu- clinical psychiatry research and practice. Although the clinical implementation of these methods is the ultimate goal, I seek to examroscientific theory as well as data collection capabilities.
ine the viability of computational psychiatry as a research method
There exist only a handful of mechanistic theories of dysfunction for developing precision psychiatry. This is not to say that we canin mental illness, such as the dopamine or glutamate hypothesis in not examine how they might fit into the clinic itself. The beauty of
schizophrenia (Seeman, 1987; Gordon, 2010). These first steps have these tools is that they can often be used predictively and to generrefuted the contemporary understanding disorders as having one- ate understanding, allowing for usage in both research and practice.
to-one biological mappings. The practical conception of disorder is However, the field is a long way from success in either domain.
defined in the Diagnostic and Statistical Manual of Mental Disor- Thus, I seek to provide a comprehensive review of computational
ders (5th ed.; DSM-V; American Psychiatric Association, 2013) on methods applied to psychiatry in general in the hopes of providing
the basis of symptom presentation. This is likely incorrect for a few a clearer picture about where the field is headed.
reasons. First, a DSM-V disorder might encapsulate subtypes with
varying etiologies. Second, the prevalence of comorbidities such
as depression and anxiety (according to Brady et al., 1992, almost BRIEFLY: WHAT IS COMPUTATIONAL PSYCHIATRY?
62%) likely indicates overlapping or interacting neural correlates
of various pathologies. Pervasive comorbidity and heterogeneity in Computational psychiatry as a discipline is divided into theorypsychologically-defined disorders have provoked the Research Do- and data-driven approaches (Huys et al., 2016). Theory-driven apmain Criteria (RDoC) approach, which seeks to rebuild psychiatric proaches model the biological processes that generate dysfunction,
whereas data-driven models remain agnostic to underlying causes,
disorders from biology upwards (Insel et al., 2010).
utilizing statistical trends in data to make inferences on new samNeuroscience faces an accelerating deluge of information which ples (Bennet et al., 2019). Montague et al. (2012) define a frameanalytic trends have not reflected. Imaging studies often fail to work for five subdomains: a) data-mining, modeling and phenoreplicate (Jahanshad, 2019). A common concern has been limited typing, b) producing new biological hypotheses, c) large-scale data
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sharing, d) biomarker discovery, and e) application to therapeutics.
Data-driven models often utilize supervised ML methods, which
have the goal of predicting labels from labelled data (Shatte et al.,
2019). Another type, unsupervised learning, extracts statistical patterns from data. Principal component analysis, a linear technique
that reduces the dimensions of data into sub-components, is popular due to its interpretability (Drysdale et al., 2017; Bondar et al.,
2020). In theoretical work, researchers seek to infer cognitive or
neurological states from behavior or neuroimaging. Models, such
as dynamic causal models (see Theoretical Approaches) seek to
represent disorder of biophysical processes and are often utilized in
conjunction with neuroimaging (Friston et al., 2017).
The bridge across the chasm between computational psychiatry research and the clinic is neither stable nor complete. In this analogy,
theory-driven approaches might be the slow yet precise construction of an overpass, whereas data-driven approaches are a ramp to
facilitate a motorcycle jump, Evil Knievel-style. The latter method
is faster, but risk and uncertainty are significantly higher as they
do not refer to any underlying disorder. Additionally, data-driven
approaches are plagued with poor methodology (Rutledge et al.,
2019).
Computational approaches can be quite relevant to some psychiatry
work (Chekroud et al., 2017), for example in predicting the risk of
a patient experiencing their first psychotic episode (Koutsouleris et
al., 2016; Adams et al., 2016) or categorizing prognosis (Kessler
et al., 2016). Other types of predictions include finding best possible treatment for a set of symptoms (Paulus & Thompson, 2019),
forecasting treatment response (Webb et al., 2018), or making diagnoses (Kalmady et al., 2019; Hahn et al., 2020). Unsupervised
approaches can find new endophenotypes of a disorder that might
cause variation in therapeutic responses (Drysdale et al., 2017;
Chand et al., 2020).

bility of these systems, they maintain insufficient generalizability,
such that clinicians have not adopted or even tested them in randomized clinical trials (Woo et al., 2017). While clinical psychiatry itself is imperfect, occasionally prescribing drugs through trial
and error, which risks long-term side effects, replacing this with a
similarly erroneous system is illogical and expensive (Chekroud
& Koutsouleris, 2017). Until computational psychiatry can create
useful solutions, it will remain out of the clinic.
It should be noted that the methods themselves are novel. Neuroimaging is both time consuming and expensive (Vu et al., 2018,
Chandler et al., 2019). The shift in perspective of fMRI studies
from functional region to whole-brain approaches (Richiardi, 2013)
emphasizes that a stronger understanding of neural computation is
necessary for selecting both methods and relevant data in research.
Neuroimaging has proved especially difficult in the search for biomarkers—Dwyer et al. (2018) notes that fMRI studies utilizing
classical statistics have a 70% false positive rate, meaning that experiments will find a statistically significant correlation in the data
more often than not, even if none is truly there. Similarly, current
treatment-predictive models do not incorporate the ability to select
multiple therapies, a regular practice in the clinic.
Woo et al. (2016) emphasizes that most computational methods for
psychiatry remain in the research stages of development. Yet data-driven approaches have often outmatched clinical counterparts
in various clinically-relevant tasks (Bzdok & Meyer-Lindenberg,
2018). So why are these results insufficient to be instantiated in
hospitals? It should be noted that most disorders lie in some abstract symptom space where different medical parameters define
the dimensions, and an expert-defined decision boundary, which
classifies data points based on their location relative to the boundary, determines diagnosis. Samples near the boundary will be difficult to classify, especially if we do not understand the nature of
the disease. In these cases, which are frequent, naive approaches
might not work as desired, leading to poor generalization among
patient types (Schultze-Lutter et al., 2018). Yet some models have
found relative success, such as Chekroud et al. (2017) which found
three generalizable symptom clusters in the Sequenced Treatment
Alternatives to Relieve Depression (STAR*D) dataset (MDD, n =
4039) that characterized antidepressant responsiveness.

In the face of overwhelming data, choosing the correct approach
is crucial. To develop clinically effective systems, all relevant data
should be considered, including electronic health records, -omics,
imaging, internet activity, and more. The abundance of data can introduce corrupting noise, which necessitates statistical techniques
to enhance signal. Furthermore, contemporary databases tend to
skew towards specific populations, such as white men or UK citizens, which must be corrected (Monteith et al., 2015). Finally, data
privacy is of utmost concern.
FAILURE TO REPLICATE

Neuroimaging studies tend to overfit, or fail to generalize beyond,

WHY HAS COMPUTATIONAL PSYCHIATRY NOT YET the experimental data. These studies suffer from the curse of dimensionality due to the small sample size. As described by Huys
TRANSLATED TO CLINICAL PRACTICE?

et al. (2016), when the number of features exceeds the number of
samples, it is possible to perfectly distinguish n patients from m
controls by using n+m-1 features. Functional connectivity matrices, which measure in fMRI how the changes in activity of one
brain region correlates with the changes in another, often have close
to 100,000 features per data point, while sample sizes are minimal,
with close to 100 subjects (Venkatesh et al., 2020). Utilizing a region of interest approach, which focuses on a particular location
of the brain, reduces dimensions drastically. Increasing the size of
While numerous studies have demonstrated the impressive capa- datasets or selecting meaningful features via regularization techIn other medicines, computational approaches are flourishing, for
example in classifying the presence of cancer (Yoo et al., 2019).
Deep learning (see Theoretical Approaches for a brief explanation)
to classify diabetic retinopathy has entered clinical trials (Rajalakshmi, 2020). However, psychiatric data are often not as straightforward, given their neurological complexity, subjective nature of
experience, and clinical heterogeneity.
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niques or theory could further mitigate these issues (Huys et al., practice?
2016).
As studies move into clinical testing, they will need even more rigAs mentioned previously, psychiatric data is noisy. Approaches that orous standards of validation. Algorithms will need to display relifocus on diagnosis directly from data, such as Zhu et al. (2018), ability (performing adequately for long periods of time), scalability
suffer from high rates of misclassifications (Chekroud, 2017) and (increasing production and distribution to customers), and ease of
do not exceed clinical accuracies as they still utilize the DSM-V implementation (allowing non-experts to utilize the technology)
criteria. Biomarkers might be shared across disorders when these (Nair et al., 2020) via clinical trials. Paulus et al. (2016) detail a
definitions are used, further confounding separability (Fernandes prospective pipeline, with phases requiring robustness, clinical validity, efficacy in a randomized clinical trial, clinical effectiveness,
& Berk, 2017).
and post-marketing refinement. Five years later, no method has
Commonly used algorithms cannot represent the complex relation- passed phase one. What further changes could facilitate progress?
ships required in psychiatry. Powerful methods such as deep learn- To develop a robust predictive or explanatory model of mental
ing have been examined but only as proof-of-concept (Durstewitz health disorders, data should be used in the same way as psychiaet al., 2019; He et al., 2020). Additionally, common optimization trists. Clinicians take the past into account via patient histories, and
techniques such as feature selection, which selects variables based so too should computational systems (Stiefel et al., 2019). Second,
on how much they improve a model, can have detrimental effects increased emphasis should be placed on theory-based research,
when attempting to generalize to new populations (Paulus et al., as models derived from theory are more likely to generalize and
potentially lead to clinically-relevant findings (Huys et al., 2016).
2019).
While machine learning is effective at tasks such as image recogniHowever, the key problem behind data-driven failures is that their tion (Kirzhevsky et al., 2012), these are not as complex as psychiamethods do not take into account the temporality and plasticity try or neuroscience. An informed approach is paramount.
of mental illness. These models capture a snapshot of the clinical
picture, abstracting away the dynamics of neurological function. This is not to say that the data-driven research should be abandoned
Thus, despite trends towards best practices, they will likely fail to entirely. Rather, it will have a position in clinical practice, perhaps
ultimately reach the acceptable threshold of generalizability for as a first pass system (see my four-step proposal), while the more
neuroscientifically-grounded models will further the analysis. Woo
clinical usage alone.
et al. (2017) note that the majority (75%) of neuroimaging studies that search for biomarkers for disorder apply a data-driven approach, underscoring the community’s excitement towards ML, but
CURRENT TRENDS
excitement is not enough. Similarly, the weak explanatory power of
The two obvious solutions to the major problems (limited data and genomics or neuroimaging is not enough to directly prove informalack of generalizability) are currently being addressed by open- tive or clinically efficacious (Chekroud, 2018).
source projects, triggering an upward trend in sample size. The
community has responded via initiatives such as the Human Brain
Project and the Human Connectome Project, which have collected THEORETICAL APPROACHES
large databases of fMRI recordings from thousands of people (Vu
et al., 2018). These projects are an excellent step in the right direc- Theory-driven models draw upon decades of neuroscience (Flagel
tion, and have yielded significant findings in basic neuroscience et al., 2019). They include biophysical simulations and behavioral
research. However, scientists seeking to use the data for clinical re- models in varying degrees of precision. They can account for hetsearch continue to be wary of these sample sizes, as well as the fact erogeneity in standard pathophysiology by adjusting various pieces
that the data regularly comes from one source, which can increase of a generalized framework to better fit individual subjects (Murray
bias (Smith & Nichols 2018). He et al. (2020) found that increasing et al., 2018). In the following subsections, I briefly detail a few
the sample size on a behavioral and demographic classification task examples of theoretical models.
from 100 subjects to 8000 improved the correlation of predicted
and ground truth labels from <0.05 to 0.25, a promising increase. Generative Models
Similarly, Hahn et al. (2020) utilized data from 27 recording sites
provided by the ENIGMA Addiction working group, which limits Generative models make inferences about unobservable neural
single-site bias.
states by sequentially taking in data, usually from neuroimaging,
Yet these are often not enough. Drysdale et al. (2017) found two
clusters of depression with different symptom profiles based on
resting state fMRI that offered separable clinical symptom profiles
and differential treatment responses to Transcranial Magnetic Stimulation on 1,188 training samples over multiple sites. Despite these
precautions, the study failed to replicate (Chekroud 2020, personal
correspondence). If computational methods cannot satisfy the robustness criteria of research, how can we hope to integrate them in

and updating the inner state of the model to better match the data.
Neuroimaging models are based on properties of functional connectivity networks, which generalize small-scale neural features
to systems-level responses (Stephan et al., 2015). fMRI, the predominant form of neuroimaging for these models, measures the
Blood-Oxygen Level Dependent (BOLD) response. This is a correlate of neural activity, recorded at a millimeter scale, that abstracts
layers of microcircuit interactions and single-neuron physiology.
The most popular form of generative models, called dynamic caus-
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al models, utilize a system of mathematic differential equations to
represent high-level features in fMRI (Stephan et al., 2015). These
can be used in psychiatry to examine how different dysfunctions
in the neural state can lead to the observations from experimental recordings. In the future, psychiatrists could fit these models to
patients to gain a deeper understanding of their specific biological
dysfunction.

Reinforcement Learning
Reinforcement learning (RL) models have seen newfound success
in representing psychiatric dysfunction. RL is a machine-learning
approach that seeks to build adaptive algorithms that can maximize
reward in a so-called environment. These are not explicitly taught
the solution, as in supervised learning, but rather have to figure it
out themselves. Neuroscientific RL is paralleled by artificial intelligence research, and contributions in one domain benefit the other. Computational algorithms such as the successor representation,
an efficient form of reinforcement learning that has empirical ties
to the function of the striatum in the brain (Dayan, 1993; Gershman, 2018), draw from both neuroscience and artificial intelligence
(AI). Huys et al. (2015) used this algorithm to argue that depressive
symptoms might draw from dysfunction in state-action evaluation,
which is a particular step in the RL framework that requires an agent
to choose a particular action given the state of the environment.
Through decision theory, an interdisciplinary field that seeks to
study how decisions are made from an algorithmic and statistical
perspective, psychiatric disorders can be viewed as occurring via
self-reinforcing behavioral dysfunction: solving the wrong problem, such as in substance addiction, solving the right problem in
the wrong manner, and solving the right problem correctly, but in
the wrong environment, such as post-traumatic stress responses
(Huys et al., 2015). These models interpret the effect of Selective
Serotonin Reuptake Inhibitors (SSRIs) as normalizing the learning
processes, which explains delayed antidepressant response via the
corollary that further experience is necessary to relearn healthy behaviors. Some neuroscientists have sought to localize various psychiatric dysfunctions to the cortico-striato-thalamo-cortical loops,
which RL connects to deficits in model-based learning or learning
algorithms that build models of their environment to play more
adaptively (Huys et al., 2016). Biological models can more precisely represent these circuits and have predictive power for disease
progression or treatment effects.

Deep Learning
Deep learning has a unique connection to neuroscience as it is based
on a reductive model of biological neural networks--neurons are
viewed as simple computation devices that gain expressive power
through their processing in a parallel and distributed manner--and
can therefore model neural systems. Image recognition networks
have been shown to replicate the visual cortex functional hierarchy
(Richards et al., 2019). These have not yet been used to explicitly
model psychiatric dysfunction, but initial forays should be expected in the near future. These systems are also effective in data-driven
algorithms, and it is plausible that they will be used in each manner.
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Hybrid Models
Hybrid models seek to utilize theory to develop features for data-driven models, which can improve predictive power by reducing
noise in the data. Brodersen et al. (2011) modelled auditory cortex
functional connectivity to identify aphasics--people who have lost
the capacity of speech due to brain damage--with 98% accuracy. In
this system, various generative models are fit to a dataset, followed
by application of supervised algorithms on the features in the generative models (Brodersen et al., 2014; Stephan et al., 2015; Wicki
et al., 2015). With a hybrid model, Frassle et al. (2020) classified
depressive patients as chronic versus remissive with 79% accuracy,
although the training set was quite small, at 85 subjects. Similar to
deep learning models, more of these approaches should be expected in the near future. Using these models might be the most effective single way to bring computational psychiatry into the clinic, as
it leverages the benefits of each type of approach.
Theoretical models lean more heavily on the research side of computational psychiatry, and therefore they have been treated with
skepticism as to their potential efficacy in a clinical setting. However, a properly designed model provides a general framework that
can be tailored to an individual patient, thus allowing for precision
medicine, much like a laboratory test provides specific measurements that can be tied to a theoretical model of physiology to gain
insight into that particular patient’s disorder.

COMPUTATIONAL APPROACHES ON CLINICAL DEPRESSION
In this section, I review a selection of studies on Major Depressive
Disorder. These are not exhaustive but indicative of current trends.

Data-Driven Studies
Patel et al. (2016) summarize early computational psychiatry
studies that use MRI data and focused on diagnosis. None of the
patient samples exceeded 80 subjects, and methods tended to be
linear, usually filtering voxels--individual pixels in an fMRI recording--with an unsupervised algorithm or functional knowledge. The
following studies utilize more modern approaches.
Islam et al. (2018) extracted data from 7,145 Facebook comments
to identify phrases that could predict depression, which they identified via a supervised model. They identified phrases with emotional, temporal, social, or perceptual qualities that significantly
predicted onset of MDD. Chekroud et al. (2018) similarly used a
dataset with 20,785 subjects from U.S national surveys to determine whether a patient would seek treatment, doing so with 70.6%
accuracy. It should be noted that this dataset was skewed female
and white (72% and 77% respectively). Relevant predictors for initiation of treatment included dropping out of college or having no
serious suicidal ideation. This model exemplifies how the computational methods discussed in this paper can not only prove relevant for clinical research, but also for a clinical setting. One would
simply have to input phrases that a patient used into this system to
determine whether or not they might be depressive.
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Webb et al. (2018) identified a subset of 216 MDD patients that
preferentially responded to sertraline (an SSRI) who were older,
employed, more neurotic and depressive, and having stronger cognitive control than average. Bondar et al. (2020) utilized an unsupervised learning algorithm to identify two symptom clusters in adolescent depressives (n = 439), in which the first (social withdrawal,
insomnia, fatigue, etc.) responded well to fluoxetine, an SSRI, and
cognitive behavioral therapy, whereas the other (increased appetite,
guilt, suicidal ideation, etc.) did not. Chekroud et al. (2016) utilized
the open-source STAR*D database to identify variables to predict
remission after citalopram treatment, finding significant contribution from employment status, psychomotor agitation, race, education, and more. Importantly, these are features that a psychiatrist
might deem relevant.

Theoretical Studies
Generative models of depression are especially difficult to develop
due to the heterogeneity of the disorder. Depression is associated
with deficits in reward learning, especially in effort valuation (Husain & Roiser, 2018). Kumar et al. (2008) localized diminished prediction error signals in the ventral striatum, which correlated with a
reduction in responsiveness to antidepressants. However, Rutledge
et al. (2017) disputed this result in a larger sample, finding that
moderately depressed patients maintained control-level reward prediction error signals. They utilized a computational model of happiness and found that severe MDD patients fit to this model differed
only from controls by a static mood intercept, which the authors interpreted as a dysfunction in higher-order processing. These results
agree with the psychological theory of baselines, which argues that
a person’s happiness at any given time is related to their baseline
quality of life (Young et al., 1996).

HOW ARE THEORY-DRIVEN MODELS BETTER SUITED TO
NEUROPSYCHIATRY?
Theory-driven models emphasize underlying neural pathology.
Biologically-driven theories attempt to explain features, such as
the dysfunction of neurotransmitter systems, that can be further
represented mathematically (Stephan et al., 2015). These models have strong predictive capabilities and can be further validated in translational animal studies, which allow for invasive
experiments (Stephan et al., 2015). Additionally, they allow for
the simulation of realistic data which could be used to predict
disease progression (Frassle et al., 2017). Data-driven approaches do not have these capabilities, and these “black-box” models--so-called because their inner workings are not fully understood--can learn discriminatory representations if the data itself
is biased, a historical problem in medicine. On the other hand,
the interpretability and strict assumptions of theoretical models
limit bias (Rutledge et al., 2019; Chandler et al., 2019).

Because psychiatric disorders have been associated with systemic neuromodulator dysfunction, this is appealing. For example,
the dopaminergic system is hypothesized to function as a prediction error signal, which is the learning signal in RL (Schultz
et al., 1997). Similarly, serotonin has been theorized as a discounting parameter in a utility function, although it certainly has
multiple functions (Huys et al., 2015). A discounting parameter
is another feature in an RL algorithm that quantifies how much
an agent “cares” about the future relative to the present, which is
measured as an exponentially weighted sum of expected rewards.
These theories provide explanations for the effects of therapeutics, while data-driven approaches cannot. Even better, generative models of adaptive plasticity can predict the mechanisms of
treatment response based on the patient’s “neurotype” (Vinogradov, 2017).
Frassle et al. (2017) note that high dimensionality—the sheer
number of features per data point—of neuroimaging introduces
high levels of variance that is challenging even for ML. However, biologically interpretable features can separate classes of patients, on which traditional ML techniques can make predictions.
An added benefit is that models can be compared to optimally
explain a set of symptoms (Bennett et al., 2019).

WHAT ARE SOME ISSUES WITH THEORY-DRIVEN MODELS?
Precise mechanistic models are needed to sufficiently capture
neural dynamics, which is a huge challenge. An incorrect or
non-parsimonious model (one that is not sufficiently simplified
while remaining precise) is likely to extract results from noise
and therefore overfit (Deco & Kringelbach, 2014). The temporospatial restrictions of neuroimaging, as mentioned above, limit
the ability of generative models to represent underlying activity.
The complexity of whole brain models makes optimization increasingly intractable (not computable in a reasonable amount
of time). Ultimately, an increase in computational power, sample
size, and algorithmic heuristics will be required to train these
systems to a functional level, just as the deep learning community found in the early 2010s (Chen & Lin, 2014). Theory-driven
approaches have mainly focused on schizophrenia to date, but future trends will include other disorders (deFilippis et al., 2019).
Like data-driven models, these systems have yet to move past the
exploratory phase (Frassle et al., 2017).
Despite the fact that these methods are still in their infancy, it is
likely that just as in other medicines, psychiatrists will soon implement artificial intelligence to aid their decision making. How
might this look in practice? In the following section, I provide
a novel four-step proposal that seeks to use the computational
tools, developed by contemporary and future research, in a maximally-effective manner to treat mental health disorders.

Generative models that holistically represent dysfunctions as parameters or dynamics can be directly connected with individual
patients, thus “treating the patient not the disease” (Stephan et A NOVEL PROPOSAL FOR THE CLINICAL IMPLEMENTAal., 2015). Such approaches can additionally account for fine- TION OF COMPUTATIONAL SYSTEMS
grained changes which ripple to the global scale and to behavior.
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In this section, I envision an integration of theory and data-driven models in clinical practice. The proposal contains four basic
steps with a recurrence paradigm for long-term treatment when
computational psychiatry approaches are sufficient for medicinal
use. The following steps require a comprehensive set of algorithms to utilize all informative data. Note that this is a general plan and would require further personalization for precision
medicine.

1. Immediate Treatment

(Mai-an Vu et al., 2018; Cearns et al., 2019). Theoretical approaches have yet to begin answering the questions desired of
computational psychiatry due to extensive methodological development. Asking the right questions is crucial, and we must take
the time to do so. Are our computational tools powerful enough
for these approaches? The answer is yes, but the more pertinent
question is whether we have the right type of data. Computational psychiatry researchers are hence cautiously optimistic about
the clinical viability of ML methods (Chekroud & Koutsouleris,
2017).

Many psychiatric disorders require immediate treatment, such as
suicidal ideation. Data-driven algorithms using information that is CONCLUSION
immediately collectable can provide initial treatment recommendations.
Perhaps it is too early to determine whether theoretical or data-driven approaches will be more efficacious for the future of
computational psychiatry and clinical practice. In all likelihood,
2. Biological data and theoretical models
both methods will be necessary. The majority of research in this
Many psychiatric disorders require immediate treatment, such as field requires a stronger theoretical foundation that will currently
suicidal ideation. Data-driven algorithms using information that is hinder the development of clinical tools, but it is still importimmediately collectable can provide initial treatment recommen- ant to consider how clinical research can translate. This will be
useful to psychiatry in general, as biologically-backed theories
dations.
can help improve the definitions and treatments of disorders in
the DSM. Psychiatritfsts will of course never be phased out, but
3. Longitudinal data collection
machine learning algorithms can pick up trends that even the exOver a specified time, the patient utilizes a smartphone applica- pert eye cannot capture in vast amounts of data. Furthermore,
tion to record relevant data, such as sleep and movement, along- efforts to create testable theoretical models must keep pace with
side surveys or virtual therapy sessions. These are factored into their counterpart as these studies will be more informative in the
the history portion of the model in order to capture the dynamics long run. Scientists, hospitals, and therapy developers will need
to communicate intensively to steer psychiatry into a new era.
of the patient’s disorder.
With time, psychiatry will soon join other disciplines in the era
of precision medicine.
4. Informed, holistic treatment
As treatment continues, the historical information is integrated
into a single, cumulative model, and a clinician designs a more
general treatment plan. Efficacy of the treatment can be revised
by repeating these steps. This precision medicine approach accounts for many of the elements of experience desired by vocal opponents to personalized psychiatry (Stiefel at al., 2019).
No single step will be sufficient, as indicated by preliminary research.

DISCUSSION
The development of computational psychiatry is still exploratory; clinical efficacy is far off. ML is a necessary tool but not
a silver bullet; applying these models unintelligently will not
suddenly solve decades-old problems. Simon (2019) makes an
excellent analogy, emphasizing that despite the hype of ML, we
cannot become like a child with a hammer, pounding anything
that looks like a nail. Contrarians argue that computational models cannot be as effective as a clinician, because they do not have
an understanding of subjective experience.
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